Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
CorMedix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
CorMedix Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
CorMedix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
CorMedix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
CorMedix Inc, Medical Devices Deals, 2012 to YTD 2018 10
CorMedix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
CorMedix Inc, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
CorMedix Enters into Co-Development Agreement with POETIC for CRMD-005 12
Licensing Agreements 13
CorMedix Enters into Licensing Agreement with NanoProteagen 13
Equity Offering 14
Cormedix to Raise USD15.61 Million in Public Offering of Shares 14
CorMedix Files Registration Statement for Public Offering of Shares for up to USD70 Million 15
CorMedix Plans to Raise up to USD20 Million in Public Offering of Shares 16
CorMedix to Raise USD5 Million in Private Placement of Preferred Shares 17
CorMedix Raises USD14 Million in Public Offering of Shares and Warrants 18
CorMedix Raises USD28.45 Million in Public Offering of Shares 20
CorMedix Completes Private Placement Of Units For US$7.4 Million 21
CorMedix Completes Private Placement Of Shares For US$1.5 Million 22
CorMedix Completes Private Placement Of Shares For US$1.5 Million 24
CorMedix Announces Private Placement Of Shares For US$2 Million 26
CorMedix Files Registration Statement For Public Offering Of Securities For US$30 Million 27
Debt Offering 28
CorMedix Completes Final Tranche Of Private Placement Of Notes For US$0.5 Million 28
CorMedix Inc – Key Competitors 29
CorMedix Inc – Key Employees 30
CorMedix Inc – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 32
Financial Announcements 32
Aug 14, 2018: Cormedix reports second quarter financial results 32
May 15, 2018: Cormedix Announces First Quarter 2018 Financial Results 33
Mar 19, 2018: Cormedix Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Business Update 34
Nov 09, 2017: CorMedix Reports Third Quarter Financial Results and Provides Business Update 36
Aug 09, 2017: CorMedix Reports Second Quarter Financial Results and Provides Business Update 38
May 10, 2017: CorMedix Reports First Quarter Financial Results and Provides Business Update 40
Mar 17, 2017: Cormedix Reports fourth quarter and full year 2016 financial results and provides business update 41
Corporate Communications 42
Aug 31, 2018: CorMedix announces NYSE american acceptance of plan to regain listing compliance 42
Aug 25, 2017: CorMedix Announces a Change to its Senior Leadership 43
Aug 07, 2017: CorMedix Appoints Gary Gelbfish, M.D., to Board of Directors 44
Jun 26, 2017: Cormedix Appoints Mehmood Khan, M.D. And Steven Lefkowitz to its Board of Directors 45
Jun 12, 2017: Cormedix Announces Changes to Board of Directors 47
Mar 02, 2017: Cormedix Appoints John L. Armstrong to Senior Leadership Team 48
Feb 01, 2017: Cormedix Announces New Appointments to Senior Leadership Team 49
Product News 50
09/07/2017: CorMedix Presents Data Demonstrating Antimicrobial Activity of Taurolidine Against Potentially Deadly Fungal Pathogen Candida auris 50
Other Significant Developments 51
Feb 27, 2018: Cormedix provides update on its financing plans in connection with its ongoing lock-it 100 clinical study 51
Appendix 52
Methodology 52
About GlobalData 52
Contact Us 52
Disclaimer 52
CorMedix Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
CorMedix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
CorMedix Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
CorMedix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
CorMedix Inc, Deals By Therapy Area, 2012 to YTD 2018 9
CorMedix Inc, Medical Devices Deals, 2012 to YTD 2018 10
CorMedix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
CorMedix Enters into Co-Development Agreement with POETIC for CRMD-005 12
CorMedix Enters into Licensing Agreement with NanoProteagen 13
Cormedix to Raise USD15.61 Million in Public Offering of Shares 14
CorMedix Files Registration Statement for Public Offering of Shares for up to USD70 Million 15
CorMedix Plans to Raise up to USD20 Million in Public Offering of Shares 16
CorMedix to Raise USD5 Million in Private Placement of Preferred Shares 17
CorMedix Raises USD14 Million in Public Offering of Shares and Warrants 18
CorMedix Raises USD28.45 Million in Public Offering of Shares 20
CorMedix Completes Private Placement Of Units For US$7.4 Million 21
CorMedix Completes Private Placement Of Shares For US$1.5 Million 22
CorMedix Completes Private Placement Of Shares For US$1.5 Million 24
CorMedix Announces Private Placement Of Shares For US$2 Million 26
CorMedix Files Registration Statement For Public Offering Of Securities For US$30 Million 27
CorMedix Completes Final Tranche Of Private Placement Of Notes For US$0.5 Million 28
CorMedix Inc, Key Competitors 29
CorMedix Inc, Key Employees 30
CorMedix Inc, Subsidiaries 31
List of Figures
CorMedix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CorMedix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CorMedix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
CorMedix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
CorMedix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
CorMedix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
CorMedix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
CorMedix Inc, Medical Devices Deals, 2012 to YTD 2018 10